Intestinal Epithelial Barrier Dysfunction in Disease and Possible Therapeutical Interventions

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|3|398-426

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.3, 2011-01, pp. : 398-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AT-1001 appears to reduce intestinal barrier dysfunction in patients with coeliac disease

By  

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Intestinal Barrier Dysfunction in Human Pathology and Aging

By  

Current Pharmaceutical Design, Vol. 22, Iss. 30, 2016-09 ,pp. : 4645-4650

Bentham Science Publishers

Access to resources Recommend Favorite

Sealing the Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1460-1470

Bentham Science Publishers

Access to resources Recommend Favorite

Mast cell activation is involved in stress‐induced epithelial barrier dysfunction in the esophagus

By  

Journal of Digestive Diseases, Vol. 16, Iss. 4, 2015-04 ,pp. : 186-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator

By  

Current Pharmaceutical Design, Vol. 13, Iss. 11, 2007-04 ,pp. : 1113-1139

Bentham Science Publishers

Access to resources Recommend Favorite